1.
Influence of age and comorbidity on survival of patients with advanced non-small-cell lung cancer
两种因素对晚期NSCLC患者预后的影响
2.
Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer
伊立替康联合放疗治疗晚期NSCLC的疗效
3.
Clinical Experience of Treating Senile Advanced Non-small Cell Lung Cancer by Erlotinib
厄洛替尼治疗老年晚期NSCLC的临床观察
4.
Clinical Significance of Tumor Markers in Patients with Advanced Non-small Cell Lung Cancer;
肿瘤标志物在晚期NSCLC诊治中的临床意义和价值
5.
Observational study on the effects of treating advanced NSCLC usingTP chemotherapy and microwave thermotherapy
微波热疗联合化疗治疗晚期NSCLC疗效观察
6.
Combination of Shenmei injection and GP chemotherapy for treatmen of advanced non-small cell lung cancer
GP方案联合参麦注射液治疗晚期NSCLC临床观察
7.
Disease control rate and survival in advanced non-small cell lung cancer after first-line chemotherapy
晚期NSCLC一线化疗疾病控制与生存关系的分析
8.
Rh-endostatin in Combination with Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
重组人内皮抑素联合化疗治疗晚期NSCLC近期疗效观察
9.
Analysis of short-term effects using accelerated-hypofractiovated three dimensional conformal radiotherapy for late-course NSCLC
三维适形后程逐步递量加速放疗局部晚期NSCLC的近期疗效观察
10.
Significance of Serum VEGF in Lung Cancer and Angiogenic Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer;
VEGF在肺癌中的临床意义及抗血管生成药物二线治疗晚期NSCLC
11.
The Clinical Observation of the Application of Jianpi Yishen Buqi Yangxue Method Treating Tumor Anemia of Xuexu Type for Advanced-Stage Nsclc Patients
健脾益肾补气养血法治疗晚期NSCLC患者血虚型癌性贫血的临床观察
12.
Investigation about Expression of RRM1 (Ribonucleo-tide Reductase M1) and the Correlation with Gemcita-bine-based Chemotherapy Sensitivity in the Advanced Non-small Cell Lung Cancer
晚期NSCLC组织RRM1的表达及与吉西他滨化疗敏感性的研究
13.
Pooled Analysis of the Trials of Erlotinib Monotherapy for Epidermal Growth Factor Receptor (EGFR)-mutant Advanced Non-small Cell Lung Cancer
厄洛替尼单药治疗EGFR突变的晚期NSCLC患者试验汇合分析
14.
Efficacy of endostar combined with vinorelbine and cisplatin in treatment of advanced non-small-cell lung cancer
重组人血管内皮抑素联合NP方案治疗晚期NSCLC的临床疗效观察
15.
Gemcitabine Combined with Kanglaite Injection in Treatment for 30 Cases with Elderly Advanced Non-small Cell Lung Cancer
吉西他滨联合康莱特注射液治疗30例老年晚期NSCLC
16.
A randomized trial comparing oxaliplatin plus docetaxel versus oxaliplatin Plus vinorelbine for the treatmen for elder patients with advanced non-small cell lung cancer
奥沙利铂加多西紫杉醇与奥沙利铂加长春瑞宾治疗43例老年晚期NSCLC的对照研究
17.
Epidermal Growth Factor Receptor Gene Mutation and the Molecular Target Therapy of Late Period Non-small-cell Lung Cancer
EGFR基因突变与晚期非小细胞肺癌（NSCLC）的分子靶向治疗
18.
Vascular Endothelial Growth Factor Expression in Stage I_A Non-Small Cell Lung Cancer and Clinical Significance;
VEGF在I_A期NSCLC中的表达和临床意义